Showing results (531-540 of 538) with videos related to

Sort By:
Pageof 54
You have reached the last page of results.This site can display upto 538 results.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO TrialMing Jie Lee, Louise-Rae Cherrill, Panagiota Zacharopoulou, et al.
The Lancet. HIV|May 27, 2026
Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trialMing J Lee, Louise-Rae Cherrill, Panagiota Zacharopoulou, et al.
Ebiomedicine|June 10, 2023
Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisitionKelly E Seaton, Yunda Huang, Shelly Karuna, et al.
The Lancet. HIV|May 11, 2026
Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, VRC07-523LS, and PGT121.414.LS infused intravenously or subcutaneously (HVTN 140/HPTN 101 part B): a phase 1, randomised trialSharana Mahomed, Carmen A Paez, Yunda Huang, et al.
Placenta|December 14, 2011
IFPA Meeting 2011 workshop report III: Placental immunology; epigenetic and microRNA-dependent gene regulation; comparative placentation; trophoblast differentiation; stem cellsW E Ackerman, J N Bulmer, A M Carter, et al.
Cancer Discovery|July 27, 2026
Systematic Targeting of Protein Complexes with Molecular COUPLrsDiane Yang, Stefan Andrew Harry, Harrison Byron Chong, et al.
Nature Medicine|May 31, 2016
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisitionMonica Vaccari, Shari N Gordon, Slim Fourati, et al.
Molecular Systems Biology|October 19, 2021
COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanismsMarek Ostaszewski, Anna Niarakis, Alexander Mazein, et al.
Pageof 54